UniProt ID | TXLNG_HUMAN | |
---|---|---|
UniProt AC | Q9NUQ3 | |
Protein Name | Gamma-taxilin | |
Gene Name | TXLNG | |
Organism | Homo sapiens (Human). | |
Sequence Length | 528 | |
Subcellular Localization | Nucleus membrane . Cytoplasm, cytosol . | |
Protein Description | May be involved in intracellular vesicle traffic. Inhibits ATF4-mediated transcription, possibly by dimerizing with ATF4 to form inactive dimers that cannot bind DNA. May be involved in regulating bone mass density through an ATF4-dependent pathway. May be involved in cell cycle progression.. | |
Protein Sequence | MATRVEEAARGRGGGAEEATEAGRGGRRRSPRQKFEIGTMEEAGICGLGVKADMLCNSQSNDILQHQGSNCGGTSNKHSLEEDEGSDFITENRNLVSPAYCTQESREEIPGGEARTDPPDGQQDSECNRNKEKTLGKEVLLLMQALNTLSTPEEKLAALCKKYADLLEESRSVQKQMKILQKKQAQIVKEKVHLQSEHSKAILARSKLESLCRELQRHNKTLKEENMQQAREEEERRKEATAHFQITLNEIQAQLEQHDIHNAKLRQENIELGEKLKKLIEQYALREEHIDKVFKHKELQQQLVDAKLQQTTQLIKEADEKHQREREFLLKEATESRHKYEQMKQQEVQLKQQLSLYMDKFEEFQTTMAKSNELFTTFRQEMEKMTKKIKKLEKETIIWRTKWENNNKALLQMAEEKTVRDKEYKALQIKLERLEKLCRALQTERNELNEKVEVLKEQVSIKAAIKAANRDLATPVMQPCTALDSHKELNTSSKRALGAHLEAEPKSQRSAVQKPPSTGSAPAIESVD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Methylation | TRVEEAARGRGGGAE CHHHHHHCCCCCCHH | 42.25 | 115368707 | |
12 | Methylation | VEEAARGRGGGAEEA HHHHHCCCCCCHHHH | 34.72 | 24129315 | |
24 | Methylation | EEATEAGRGGRRRSP HHHHHCCCCCCCCCH | 51.98 | 24129315 | |
27 | Methylation | TEAGRGGRRRSPRQK HHCCCCCCCCCHHHC | 33.39 | 30989833 | |
30 | Phosphorylation | GRGGRRRSPRQKFEI CCCCCCCCHHHCEEC | 23.71 | 22817900 | |
43 | Ubiquitination | EIGTMEEAGICGLGV ECCCHHHHCCCCCCC | 10.19 | 32015554 | |
54 | Sulfoxidation | GLGVKADMLCNSQSN CCCCCHHHHCCCCCC | 5.70 | 21406390 | |
58 | Phosphorylation | KADMLCNSQSNDILQ CHHHHCCCCCCCHHH | 33.71 | 23663014 | |
60 | Phosphorylation | DMLCNSQSNDILQHQ HHHCCCCCCCHHHHC | 35.97 | 23663014 | |
69 | Phosphorylation | DILQHQGSNCGGTSN CHHHHCCCCCCCCCC | 23.52 | 29978859 | |
70 | Ubiquitination | ILQHQGSNCGGTSNK HHHHCCCCCCCCCCC | 34.96 | 21890473 | |
72 | Ubiquitination | QHQGSNCGGTSNKHS HHCCCCCCCCCCCCC | 46.81 | 22817900 | |
73 | Ubiquitination | HQGSNCGGTSNKHSL HCCCCCCCCCCCCCC | 28.33 | 22817900 | |
74 | Phosphorylation | QGSNCGGTSNKHSLE CCCCCCCCCCCCCCC | 17.89 | 26714015 | |
75 | Ubiquitination | GSNCGGTSNKHSLEE CCCCCCCCCCCCCCC | 47.35 | 32015554 | |
75 | Phosphorylation | GSNCGGTSNKHSLEE CCCCCCCCCCCCCCC | 47.35 | 27251275 | |
79 | Phosphorylation | GGTSNKHSLEEDEGS CCCCCCCCCCCCCCC | 38.80 | 30576142 | |
86 | Phosphorylation | SLEEDEGSDFITENR CCCCCCCCCCCCCCC | 27.57 | 25159151 | |
88 | Ubiquitination | EEDEGSDFITENRNL CCCCCCCCCCCCCCC | 8.79 | 24816145 | |
90 | Phosphorylation | DEGSDFITENRNLVS CCCCCCCCCCCCCCC | 27.48 | 29978859 | |
97 | Phosphorylation | TENRNLVSPAYCTQE CCCCCCCCCCCCCHH | 13.64 | 19664994 | |
100 | Phosphorylation | RNLVSPAYCTQESRE CCCCCCCCCCHHHHC | 10.22 | 23927012 | |
102 | Phosphorylation | LVSPAYCTQESREEI CCCCCCCCHHHHCCC | 23.77 | 22167270 | |
105 | Phosphorylation | PAYCTQESREEIPGG CCCCCHHHHCCCCCC | 34.86 | 23927012 | |
116 | Phosphorylation | IPGGEARTDPPDGQQ CCCCCCCCCCCCCCC | 60.96 | 26074081 | |
126 | Ubiquitination | PDGQQDSECNRNKEK CCCCCCCCCCHHHCH | 44.06 | 24816145 | |
134 | Phosphorylation | CNRNKEKTLGKEVLL CCHHHCHHHHHHHHH | 41.66 | - | |
143 | Ubiquitination | GKEVLLLMQALNTLS HHHHHHHHHHHHCCC | 1.90 | 33845483 | |
143 | Ubiquitination | GKEVLLLMQALNTLS HHHHHHHHHHHHCCC | 1.90 | 21890473 | |
143 | Neddylation | GKEVLLLMQALNTLS HHHHHHHHHHHHCCC | 1.90 | 32015554 | |
145 | Ubiquitination | EVLLLMQALNTLSTP HHHHHHHHHHCCCCH | 6.71 | 22817900 | |
146 | Ubiquitination | VLLLMQALNTLSTPE HHHHHHHHHCCCCHH | 2.57 | 22817900 | |
161 | Ubiquitination | EKLAALCKKYADLLE HHHHHHHHHHHHHHH | 50.06 | 32015554 | |
162 | Acetylation | KLAALCKKYADLLEE HHHHHHHHHHHHHHH | 44.68 | 26051181 | |
163 | Phosphorylation | LAALCKKYADLLEES HHHHHHHHHHHHHHH | 7.28 | 20068231 | |
170 | Phosphorylation | YADLLEESRSVQKQM HHHHHHHHHHHHHHH | 22.08 | 20068231 | |
172 | Phosphorylation | DLLEESRSVQKQMKI HHHHHHHHHHHHHHH | 37.87 | 28509920 | |
175 | Ubiquitination | EESRSVQKQMKILQK HHHHHHHHHHHHHHH | 50.64 | 29967540 | |
199 | Ubiquitination | VHLQSEHSKAILARS HHCCCHHHHHHHHHH | 21.52 | 24816145 | |
207 | Ubiquitination | KAILARSKLESLCRE HHHHHHHHHHHHHHH | 51.20 | 32015554 | |
210 | Phosphorylation | LARSKLESLCRELQR HHHHHHHHHHHHHHH | 43.11 | 24719451 | |
220 | Ubiquitination | RELQRHNKTLKEENM HHHHHHHHHHHHHHH | 49.46 | 24816145 | |
223 | Acetylation | QRHNKTLKEENMQQA HHHHHHHHHHHHHHH | 69.11 | 26051181 | |
238 | Ubiquitination | REEEERRKEATAHFQ HHHHHHHHHHHHHHH | 58.90 | 32015554 | |
275 | Neddylation | ENIELGEKLKKLIEQ HHHHHHHHHHHHHHH | 64.90 | 32015554 | |
275 | Ubiquitination | ENIELGEKLKKLIEQ HHHHHHHHHHHHHHH | 64.90 | 22817900 | |
277 | Ubiquitination | IELGEKLKKLIEQYA HHHHHHHHHHHHHHH | 57.51 | 22817900 | |
278 | Ubiquitination | ELGEKLKKLIEQYAL HHHHHHHHHHHHHHH | 66.20 | 22817900 | |
283 | Phosphorylation | LKKLIEQYALREEHI HHHHHHHHHHHHHHH | 8.53 | 20068231 | |
292 | Acetylation | LREEHIDKVFKHKEL HHHHHHHHHHCCHHH | 49.30 | 26051181 | |
292 | Ubiquitination | LREEHIDKVFKHKEL HHHHHHHHHHCCHHH | 49.30 | - | |
301 | Ubiquitination | FKHKELQQQLVDAKL HCCHHHHHHHHHHHH | 51.72 | 24816145 | |
307 | Ubiquitination | QQQLVDAKLQQTTQL HHHHHHHHHHHHHHH | 42.22 | 29967540 | |
309 | Ubiquitination | QLVDAKLQQTTQLIK HHHHHHHHHHHHHHH | 37.56 | 24816145 | |
319 | Ubiquitination | TQLIKEADEKHQRER HHHHHHHHHHHHHHH | 67.57 | 29967540 | |
331 | Ubiquitination | REREFLLKEATESRH HHHHHHHHHHHHHHH | 47.66 | 24816145 | |
370 | Ubiquitination | EFQTTMAKSNELFTT HHHHHHHHHCHHHHH | 42.88 | 32015554 | |
371 | Phosphorylation | FQTTMAKSNELFTTF HHHHHHHHCHHHHHH | 26.46 | 20068231 | |
374 | Ubiquitination | TMAKSNELFTTFRQE HHHHHCHHHHHHHHH | 5.59 | 24816145 | |
376 | Phosphorylation | AKSNELFTTFRQEME HHHCHHHHHHHHHHH | 37.33 | 20068231 | |
377 | Phosphorylation | KSNELFTTFRQEMEK HHCHHHHHHHHHHHH | 14.97 | 20068231 | |
382 | Ubiquitination | FTTFRQEMEKMTKKI HHHHHHHHHHHHHHH | 4.55 | 24816145 | |
386 | Phosphorylation | RQEMEKMTKKIKKLE HHHHHHHHHHHHHHH | 40.01 | 17081983 | |
388 | Acetylation | EMEKMTKKIKKLEKE HHHHHHHHHHHHHHH | 51.06 | 12436935 | |
402 | Acetylation | ETIIWRTKWENNNKA HHHHEEECCCCCHHH | 43.89 | 25953088 | |
430 | Acetylation | EYKALQIKLERLEKL HHHHHHHHHHHHHHH | 31.19 | 26051181 | |
451 | Ubiquitination | ERNELNEKVEVLKEQ HHHHHHHHHHHHHHH | 42.49 | 29967540 | |
460 | Phosphorylation | EVLKEQVSIKAAIKA HHHHHHHHHHHHHHH | 20.33 | 21406692 | |
474 | Phosphorylation | AANRDLATPVMQPCT HHCCCCCCCCCCCCC | 24.58 | 26462736 | |
481 | Phosphorylation | TPVMQPCTALDSHKE CCCCCCCCHHHHHCC | 36.62 | - | |
487 | Acetylation | CTALDSHKELNTSSK CCHHHHHCCCCCHHH | 68.78 | 26051181 | |
491 | Phosphorylation | DSHKELNTSSKRALG HHHCCCCCHHHHHHH | 47.18 | 29214152 | |
506 | Ubiquitination | AHLEAEPKSQRSAVQ HHHCCCCHHHHHCCC | 51.21 | 24816145 | |
510 | Phosphorylation | AEPKSQRSAVQKPPS CCCHHHHHCCCCCCC | 25.75 | 29396449 | |
514 | Ubiquitination | SQRSAVQKPPSTGSA HHHHCCCCCCCCCCC | 52.90 | 24816145 | |
514 | Acetylation | SQRSAVQKPPSTGSA HHHHCCCCCCCCCCC | 52.90 | 30593163 | |
517 | Phosphorylation | SAVQKPPSTGSAPAI HCCCCCCCCCCCCCC | 54.66 | 25159151 | |
518 | Phosphorylation | AVQKPPSTGSAPAIE CCCCCCCCCCCCCCC | 40.71 | 25159151 | |
520 | Phosphorylation | QKPPSTGSAPAIESV CCCCCCCCCCCCCCC | 31.03 | 25159151 | |
526 | Phosphorylation | GSAPAIESVD----- CCCCCCCCCC----- | 26.02 | 30108239 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TXLNG_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TXLNG_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TXLNG_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TBK1_HUMAN | TBK1 | physical | 21903422 | |
TXLNA_HUMAN | TXLNA | physical | 21903422 | |
TXLNB_HUMAN | TXLNB | physical | 21903422 | |
WIPF2_HUMAN | WIPF2 | physical | 22939629 | |
UBP3_HUMAN | USP3 | physical | 22939629 | |
CHAP1_HUMAN | CHAMP1 | physical | 22939629 | |
ZC11A_HUMAN | ZC3H11A | physical | 22939629 | |
UBA1_HUMAN | UBA1 | physical | 22939629 | |
CDV3_HUMAN | CDV3 | physical | 26344197 | |
DDX17_HUMAN | DDX17 | physical | 26344197 | |
TXLNA_HUMAN | TXLNA | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-86, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-517, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97 AND SER-105, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-386, AND MASSSPECTROMETRY. |